US Patent

US12539314 — Aqueous oral compositions including potassium chloride

Formulation · Assigned to Genus Lifesciences Inc · Expires 2039-03-07 · 13y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects an oral liquid composition of potassium chloride that is free of alcohol and parabens and has enhanced stability.

USPTO Abstract

The present disclosure provides an oral liquid composition comprising potassium chloride, free of alcohol, free of parabens, and with enhanced stability. The present disclosure further provides methods of using the oral liquid compositions comprising potassium chloride, and which are free of alcohol and parabens, for the treatment of hypokalemia in patients with or without metabolic alkalosis.

Drugs covered by this patent

Patent Metadata

Patent number
US12539314
Jurisdiction
US
Classification
Formulation
Expires
2039-03-07
Drug substance claim
No
Drug product claim
Yes
Assignee
Genus Lifesciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.